MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

LeMaitre Vascular Company Profile (NASDAQ:LMAT)

Consensus Ratings for LeMaitre Vascular (NASDAQ:LMAT) (?)
Ratings Breakdown: 8 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $17.25 (4.04% upside)

Analysts' Ratings History for LeMaitre Vascular (NASDAQ:LMAT)
Show:
DateFirmActionRatingPrice TargetActions
2/27/2016Barrington ResearchReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/25/2016Roth CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/25/2016Canaccord GenuityReiterated RatingBuy$18.50 -> $16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/8/2016SidotiUpgradeNeutral -> Buy$17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/7/2015Dougherty & CoBoost Price TargetBuy$16.00 -> $19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/4/2015Brean CapitalReiterated RatingBuy$15.00 -> $17.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/4/2015Benchmark Co.Boost Price Target$15.00 -> $18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/4/2015Stifel NicolausBoost Price TargetBuy$14.00 -> $17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/19/2014ING GroupInitiated CoverageBuy$11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/1/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha